查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1722864

2025 年至 2033 年透皮贴片市场规模、份额、趋势及预测（按类型、配销通路、应用及地区）

Transdermal Skin Patches Market Size, Share, Trends and Forecast by Type, Distribution Channel, Application, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球透皮贴片市场规模价值 82.1 亿美元。展望未来， IMARC Group估计到 2033 年市场规模将达到 115.6 亿美元，2025-2033 年期间的复合年增长率为 3.69%。北美目前占据市场主导地位，到 2024 年将占据 35.5% 的显着市场。由于先进的医疗保健基础设施支持创新的透皮技术，市场正在经历成长。慢性病的高发生率确保了对有效、非侵入性治疗方案的持续需求。除此之外，强大的製药公司影响力和良好的监管框架推动了产品开发和监管审批，巩固了该地区在全球透皮贴片市场份额中的重要性。

透皮贴片是一种非侵入性且易于使用的药物传递方法，可在预定时间内将恆定且一致的治疗剂量输送到血液中。它们由背衬、药物、薄膜、黏合剂、衬垫、化学增强剂和渗透剂、物理辅助剂和离子电渗疗法等低电流组成。根据皮肤的特性和贴片的设计，它们提供一致的扩散率。如今，它们在世界各地被广泛用作化妆品、外用药和透皮给药系统。

透皮贴片市场趋势：

透皮贴片可有效治疗心臟和内分泌失调、偏头痛、帕金森氏症、阿兹海默症、中风、人类免疫缺陷病毒 (HIV)、骨质疏鬆症和不安腿症候群。因此，患有这些疾病的人口比例显着增加是推动市场成长的关键因素之一。此外，这些贴片有助于避免传统的口服药物途径，减少静脉或肠外治疗的不便，并防止胃肠道毒性、噁心和呕吐。此外，由于使用方便，透皮贴片越来越受到人们的青睐，可以提高患者在长期治疗慢性疼痛和戒烟治疗中的依从性。除此之外，对价格实惠、疗效更好的治疗方法的需求不断增加，加上不同类别药物临床试验数量的显着增加，对市场产生了积极影响。此外，压敏胶合剂和渗透促进剂的引入，可增加产品扩散并增强药物保留能力，预计将为市场参与者提供有利可图的机会，并在未来几年扩大透皮贴片在全球范围内的应用。

本报告回答的关键问题

  • 透皮贴片市场有多大？透皮贴片市场的未来前景如何？
  • 推动透皮贴片市场发展的关键因素有哪些？
  • 哪个地区占据了透皮贴片最大的市场份额？
  • 全球透皮贴片市场领先的公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球透皮贴片市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场细分：依类型

  • 单层药物黏合剂
  • 多层药物黏合剂
  • 矩阵
  • 其他的

第七章：市场区隔：按配销通路

  • 医院药房
  • 零售药局
  • 网上商店

第 8 章：市场区隔：按应用

  • 缓解疼痛
  • 减少和戒烟援助
  • 膀胱过动症
  • 荷尔蒙疗法
  • 其他的

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第十章：SWOT分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • 3M Company
    • AdhexPharma
    • LTS Lohmann Therapie-Systeme AG
    • Luye Pharma Group
    • Medherant Limited
    • Nitto Denko Corporation
    • Noven Pharmaceuticals Inc. (Hisamitsu Pharmaceutical Co. Inc.)
    • Prosolus Inc.
    • Samyang Holdings Corporation
    • Tapemark
    • Teikoku Pharma USA Inc. (Teikoku Seiyaku Co. Ltd)
    • tesa SE (Beiersdorf AG)
    • Teva Pharmaceutical Industries Ltd
Product Code: SR112025A5142

The global transdermal skin patches market size was valued at USD 8.21 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 11.56 Billion by 2033, exhibiting a CAGR of 3.69% during 2025-2033. North America currently dominates the market, holding a significant market share of 35.5% in 2024. The market is experiencing growth because of advanced healthcare infrastructure supporting innovative transdermal technologies. High prevalence of chronic conditions ensures sustained demand for effective, non-invasive treatment options. Besides this, strong presence of pharmaceutical companies and favorable regulatory frameworks drive product development and regulatory approvals, solidifying the region's significance in the global transdermal skin patches market share.

Transdermal skin patches refer to a non-invasive and easy to use drug delivery method of administering constant and consistent therapeutic dosages into the bloodstream over a predetermined time. They consist of backings, drugs, membranes, adhesives, liners, chemical enhancers and permeators, physical aids, and low electrical current like iontophoresis. They provide a consistent diffusion rate, depending on the characteristics of the skin and the design of the patch. They are nowadays widely used as cosmetic, topical, and transdermal delivery systems around the world.

Transdermal Skin Patches Market Trends:

Transdermal skin patches are effective for treating cardiac and hormonal disorders, migraine, Parkinson's disease, Alzheimer's, stroke, human immunodeficiency virus (HIV), osteoporosis, and restless leg syndrome. Thus, a significant increase in the percentage of the population suffering from these ailments represents one of the key factors impelling the market growth. Moreover, these patches help avoid the traditional oral route for ingesting medicines, lower the inconvenience caused due to intravenous or parenteral therapies, and prevent gastrointestinal toxicity, nausea, and vomiting. Furthermore, due to the ease of administration, transdermal skin patches are gaining traction to improve the compliance of the patient during prolonged treatments for chronic pains and in smoking cessation therapy. Apart from this, the escalating demand for better therapeutics at affordable costs, coupled with a significant rise in the number of clinical trials of different drugs classes, is positively influencing the market. Furthermore, the introduction of pressure-sensitive adhesives and permeation enhancers, which lead to increased product diffusion and enhanced drug retention ability, is anticipated to provide lucrative opportunities to market players and expand the application of transdermal skin patches across the globe in the coming years.

Key Market Segmentation:

Breakup by Type:

  • Single-layer Drug-in-Adhesive
  • Multi-layer Drug-in-Adhesive
  • Matrix
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Stores

Breakup by Application:

  • Pain Relief
  • Smoking Reduction and Cessation Aid
  • Overactive Bladder
  • Hormonal Therapy
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, AdhexPharma, LTS Lohmann Therapie-Systeme AG, Luye Pharma Group, Medherant Limited, Nitto Denko Corporation, Noven Pharmaceuticals Inc. (Hisamitsu Pharmaceutical Co. Inc.), Prosolus Inc., Samyang Holdings Corporation, Tapemark, Teikoku Pharma USA Inc. (Teikoku Seiyaku Co. Ltd), tesa SE (Beiersdorf AG) and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report

  • 1.How big is the transdermal skin patches market?
  • 2.What is the future outlook of transdermal skin patches market?
  • 3.What are the key factors driving the transdermal skin patches market?
  • 4.Which region accounts for the largest transdermal skin patches market share?
  • 5.Which are the leading companies in the global transdermal skin patches market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Transdermal Skin Patches Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Single-layer Drug-in-Adhesive
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Multi-layer Drug-in-Adhesive
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Matrix
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Distribution Channel

  • 7.1 Hospital Pharmacies
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Retail Pharmacies
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Online Stores
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Pain Relief
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Smoking Reduction and Cessation Aid
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Overactive Bladder
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Hormonal Therapy
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 3M Company
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 AdhexPharma
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 LTS Lohmann Therapie-Systeme AG
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Luye Pharma Group
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Medherant Limited
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Nitto Denko Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Noven Pharmaceuticals Inc. (Hisamitsu Pharmaceutical Co. Inc.)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 Prosolus Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Samyang Holdings Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 Tapemark
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Teikoku Pharma USA Inc. (Teikoku Seiyaku Co. Ltd)
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 tesa SE (Beiersdorf AG)
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
    • 14.3.13 Teva Pharmaceutical Industries Ltd
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Transdermal Skin Patches Market: Major Drivers and Challenges
  • Figure 2: Global: Transdermal Skin Patches Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Transdermal Skin Patches Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Transdermal Skin Patches Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Transdermal Skin Patches Market: Breakup by Distribution Channel (in %), 2024
  • Figure 6: Global: Transdermal Skin Patches Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Transdermal Skin Patches Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Transdermal Skin Patches (Single-layer Drug-in-Adhesive) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Transdermal Skin Patches (Single-layer Drug-in-Adhesive) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Transdermal Skin Patches (Multi-layer Drug-in-Adhesive) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Transdermal Skin Patches (Multi-layer Drug-in-Adhesive) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Transdermal Skin Patches (Matrix) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Transdermal Skin Patches (Matrix) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Transdermal Skin Patches (Other Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Transdermal Skin Patches (Other Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Transdermal Skin Patches (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Transdermal Skin Patches (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Transdermal Skin Patches (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Transdermal Skin Patches (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Transdermal Skin Patches (Online Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Transdermal Skin Patches (Online Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Transdermal Skin Patches (Pain Relief) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Transdermal Skin Patches (Pain Relief) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Transdermal Skin Patches (Smoking Reduction and Cessation Aid) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Transdermal Skin Patches (Smoking Reduction and Cessation Aid) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Transdermal Skin Patches (Overactive Bladder) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Transdermal Skin Patches (Overactive Bladder) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Transdermal Skin Patches (Hormonal Therapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Transdermal Skin Patches (Hormonal Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Transdermal Skin Patches (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Transdermal Skin Patches (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: North America: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: North America: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: United States: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: United States: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Canada: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Canada: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Asia-Pacific: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Asia-Pacific: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: China: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: China: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Japan: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Japan: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: India: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: India: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: South Korea: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: South Korea: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Australia: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Australia: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Indonesia: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Indonesia: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Others: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Others: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Europe: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Europe: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Germany: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Germany: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: France: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: France: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: United Kingdom: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: United Kingdom: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Italy: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Italy: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Spain: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Spain: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Russia: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Russia: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Others: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Others: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Latin America: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Latin America: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Brazil: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Brazil: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Mexico: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Mexico: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Others: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Others: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Middle East and Africa: Transdermal Skin Patches Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Middle East and Africa: Transdermal Skin Patches Market: Breakup by Country (in %), 2024
  • Figure 80: Middle East and Africa: Transdermal Skin Patches Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Global: Transdermal Skin Patches Industry: SWOT Analysis
  • Figure 82: Global: Transdermal Skin Patches Industry: Value Chain Analysis
  • Figure 83: Global: Transdermal Skin Patches Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Transdermal Skin Patches Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Transdermal Skin Patches Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Transdermal Skin Patches Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 4: Global: Transdermal Skin Patches Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Transdermal Skin Patches Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Transdermal Skin Patches Market: Competitive Structure
  • Table 7: Global: Transdermal Skin Patches Market: Key Players